15 February 2022
Four articles, led or co-authored by Oxford researchers in the department, make the BMJ's top 10 list for the most read and published articles of 2021.
16 December 2021
Led by the University of Oxford, a team of UK-based researchers have today reported results of the largest ever study to compare the risks of cardiovascular events, such as myocarditis, pericarditis, and cardiac arrhythmia, between different vaccines and COVID-19 infection, and the first to investigate the association between cardiac events and the Oxford-AstraZeneca vaccine.
Department Researchers work highlighted at NCRI festival: Fewer cases of children’s cancer picked up during COVID pandemic
12 November 2021
A study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic. The research, presented at the NCRI Festival, also shows that children who were diagnosed with cancer during the first wave of the pandemic were more likely to have been admitted to intensive care prior to their diagnosis.
Department Researchers work highlighted at NCRI festival: New symptoms identified that could help doctors diagnose pancreatic cancer
8 November 2021
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms – feeling thirsty and having dark urine – in a study presented today (Monday, 8th Jan) at the NCRI Festival.
25 October 2021
Researchers from across the UK, led by the University of Oxford, have today reported on the risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.
19 October 2021
Dr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.
11 October 2021
A collaboration which used anonymised GP records to identify 1.5m people most at risk from Covid-19 and prioritise them for vaccination has won the prestigious John Perry Prize for computing innovation in primary care.
30 September 2021
Use of menopausal hormone therapy (MHT), also known as hormone replacement therapy, HRT) is not associated with an increased risk of developing dementia, regardless of hormone type, dose, or duration, conclude a team of researchers from across the UK.
QCovid highly commended for ‘best use of technology in Patient Safety’ at the 2021 HSJ Patient Safety Awards
23 September 2021
Professor Julia Hippisley-Cox and her team have been Highly Commended in the ‘Best use of technology in Patient Safety’ category for the QCovid risk calculator at this year’s Health Service Journal Patient Safety Awards.
Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool
20 September 2021
New algorithm predicts those most at risk of serious Covid-19 outcomes from 14 or more days after second vaccination dose, when substantial immunity is expected to have developed Authors hope this new risk tool will allow those who perceive risk to be high to make more informed decisions regarding shielding and potentially inform policy and clinical decisions on booster vaccine doses and monoclonal antibodies
10 August 2021
Research into the risk of hospital admission from COVID-19 is recognised with a "Best Research Paper Award" from the journal Heart.
New study shows potential link between bodyweight and risk of severe COVID-19, especially for younger adults
29 April 2021
The first large study to report the effect of bodyweight on risk of worse outcomes from COVID-19 across the full range of body mass index (BMI) is published today in The Lancet Diabetes and Endocrinology journal.
29 October 2020
Results add to existing knowledge and should help doctors and women make the best treatment choices
24 January 2020
Professor Julia Hippisley-Cox and the QResearch electronic health records database are to contribute to a prestigious Cancer Research UK-funded programme to research the earlier detection of hepatocellular carcinoma.